BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10752973)

  • 1. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
    Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
    Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of SEER-Medicare data for measuring cancer surgery.
    Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of Medicare claims data for measuring cancer stage.
    Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
    Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construct validity of medicare chemotherapy claims: the case of 5FU.
    Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA
    Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying radiation therapy using SEER-Medicare-linked data.
    Virnig BA; Warren JL; Cooper GS; Klabunde CN; Schussler N; Freeman J
    Med Care; 2002 Aug; 40(8 Suppl):IV-49-54. PubMed ID: 12187168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
    Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
    Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
    Lin CC; Virgo KS
    Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
    Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
    BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
    Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
    Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
    Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of breast conserving surgery: linking insurance claims with tumor registry data.
    Maskarinec G; Dhakal S; Yamashiro G; Issell BF
    BMC Cancer; 2002; 2():3. PubMed ID: 11879527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of SEER Treatment Data With Medicare Claims.
    Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
    Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Cancer-Directed Surgeries in Medicare Claims: A Validation Study Using SEER-Medicare Data.
    Lavery JA; Lipitz-Snyderman A; Li DG; Bach PB; Panageas KS
    JCO Clin Cancer Inform; 2019 Feb; 3():1-24. PubMed ID: 30715928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
    Gold HT; Do HT
    Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans.
    Ramsey SD; Scoggins JF; Blough DK; McDermott CL; Reyes CM
    J Manag Care Pharm; 2009 Oct; 15(8):659-68. PubMed ID: 19803555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment patterns for prostate cancer: comparison of Medicare claims data to medical record review.
    Fleming ST; Hamilton AS; Sabatino SA; Kimmick GG; Wu XC; Owen JB; Huang B; Hwang W;
    Med Care; 2014 Sep; 52(9):e58-64. PubMed ID: 23222532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s.
    Kim SP; Feinglass J; Bennett CL; Lyons T; Simon C; Weinberg MN; Talamonti MS
    Cancer Invest; 2004; 22(2):225-33. PubMed ID: 15199605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Place of Death of Individuals with Terminal Cancer: New Insights from Medicare Hospice Place-of-Service Codes.
    Jarosek SL; Shippee TP; Virnig BA
    J Am Geriatr Soc; 2016 Sep; 64(9):1815-22. PubMed ID: 27534517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
    Wang K; Sheets NC; Basak R; Chen RC
    Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.